AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Bromazepam in Nigeria
9 products registered with NAFDAC — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Talen 1.5 mg Tablets** Tablet | A4-7544 | Swiss Pharma Nigeria Limited | active | 30 Aug 2028 |
| Talen 3 mg Tablets** Tablet | A4-7435 | Swiss Pharma Nigeria Limited | active | 30 Aug 2028 |
| Albetan 1.5 mg Tablet Tablet | B4-0082 | Alben Health Care Industries Ltd | active | 5 Jul 2028 |
| Albetan 3 mg Tablet Tablet | B4-0083 | Alben Health Care Industries Ltd | active | 24 May 2028 |
| Bromatan 3 mg** Tablet | A4-2662 | May & Baker Nigeria PLC | active | 6 May 2026 |
| Bromatan 1.5 mg** Tablet | A4-2663 | May & Baker Nigeria PLC | active | 6 May 2026 |
| DGF Broletan Tablet Tablet | A11-0382 | Drugfield Pharmaceuticals Limited | active | 20 Dec 2025 |
| Zunatan Bromazepam Tablet# Tablet | A11-0028 | Zunamediks Pharm Limited | active | 20 Dec 2025 |
| Replek Bromazepam 3 mg Tablets Tablet | C4-1228 | Bio-Generics Nigeria Limited | active | 9 Nov 2025 |
Bromazepam — NAFDAC Registration Details
NAFDAC (Nigeria) has 9 registered products containing Bromazepam, of which 9 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Bromazepam registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.